Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Microbiological Testing Water Market

ID: MRFR/CnM/23535-HCR
111 Pages
Chitranshi Jaiswal
Last Updated: April 24, 2026

Microbiological Testing Of Water Market Research Report By Test Type (Total Coliforms, E. coli, Fecal Enterococci, Legionella, Pseudomonas, Others), By Sample Type (Water, Wastewater, Industrial Water, Groundwater, Drinking Water, Others), By Methodology (Culture-Based Methods, Molecular Methods, Immunological Methods, Others), By End-Use (Municipal Water Treatment, Industrial Water Treatment, Food and Beverage Industry, Healthcare Industry, Research and Development, Others) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Microbiological Testing Water Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Chemicals and Materials, BY Test Type (USD Billion)
  49.     4.1.1 Total Coliforms
  50.     4.1.2 E. coli
  51.     4.1.3 Fecal Enterococci
  52.     4.1.4 Legionella
  53.     4.1.5 Pseudomonas
  54.     4.1.6 Others
  55.   4.2 Chemicals and Materials, BY Sample Type (USD Billion)
  56.     4.2.1 Water
  57.     4.2.2 Wastewater
  58.     4.2.3 Industrial Water
  59.     4.2.4 Groundwater
  60.     4.2.5 Drinking Water
  61.     4.2.6 Others
  62.   4.3 Chemicals and Materials, BY Methodology (USD Billion)
  63.     4.3.1 Culture-Based Methods
  64.     4.3.2 Molecular Methods
  65.     4.3.3 Immunological Methods
  66.     4.3.4 Others
  67.   4.4 Chemicals and Materials, BY End-Use (USD Billion)
  68.     4.4.1 Municipal Water Treatment
  69.     4.4.2 Industrial Water Treatment
  70.     4.4.3 Food and Beverage Industry
  71.     4.4.4 Healthcare Industry
  72.     4.4.5 Research and Development
  73.     4.4.6 Others
  74.   4.5 Chemicals and Materials, BY Region (USD Billion)
  75.     4.5.1 North America
  76.       4.5.1.1 US
  77.       4.5.1.2 Canada
  78.     4.5.2 Europe
  79.       4.5.2.1 Germany
  80.       4.5.2.2 UK
  81.       4.5.2.3 France
  82.       4.5.2.4 Russia
  83.       4.5.2.5 Italy
  84.       4.5.2.6 Spain
  85.       4.5.2.7 Rest of Europe
  86.     4.5.3 APAC
  87.       4.5.3.1 China
  88.       4.5.3.2 India
  89.       4.5.3.3 Japan
  90.       4.5.3.4 South Korea
  91.       4.5.3.5 Malaysia
  92.       4.5.3.6 Thailand
  93.       4.5.3.7 Indonesia
  94.       4.5.3.8 Rest of APAC
  95.     4.5.4 South America
  96.       4.5.4.1 Brazil
  97.       4.5.4.2 Mexico
  98.       4.5.4.3 Argentina
  99.       4.5.4.4 Rest of South America
  100.     4.5.5 MEA
  101.       4.5.5.1 GCC Countries
  102.       4.5.5.2 South Africa
  103.       4.5.5.3 Rest of MEA
  104. 5 SECTION V: COMPETITIVE ANALYSIS
  105.   5.1 Competitive Landscape
  106.     5.1.1 Overview
  107.     5.1.2 Competitive Analysis
  108.     5.1.3 Market share Analysis
  109.     5.1.4 Major Growth Strategy in the Chemicals and Materials
  110.     5.1.5 Competitive Benchmarking
  111.     5.1.6 Leading Players in Terms of Number of Developments in the Chemicals and Materials
  112.     5.1.7 Key developments and growth strategies
  113.       5.1.7.1 New Product Launch/Service Deployment
  114.       5.1.7.2 Merger & Acquisitions
  115.       5.1.7.3 Joint Ventures
  116.     5.1.8 Major Players Financial Matrix
  117.       5.1.8.1 Sales and Operating Income
  118.       5.1.8.2 Major Players R&D Expenditure. 2023
  119.   5.2 Company Profiles
  120.     5.2.1 Thermo Fisher Scientific (US)
  121.       5.2.1.1 Financial Overview
  122.       5.2.1.2 Products Offered
  123.       5.2.1.3 Key Developments
  124.       5.2.1.4 SWOT Analysis
  125.       5.2.1.5 Key Strategies
  126.     5.2.2 Hach Company (US)
  127.       5.2.2.1 Financial Overview
  128.       5.2.2.2 Products Offered
  129.       5.2.2.3 Key Developments
  130.       5.2.2.4 SWOT Analysis
  131.       5.2.2.5 Key Strategies
  132.     5.2.3 Merck KGaA (DE)
  133.       5.2.3.1 Financial Overview
  134.       5.2.3.2 Products Offered
  135.       5.2.3.3 Key Developments
  136.       5.2.3.4 SWOT Analysis
  137.       5.2.3.5 Key Strategies
  138.     5.2.4 Pace Analytical Services (US)
  139.       5.2.4.1 Financial Overview
  140.       5.2.4.2 Products Offered
  141.       5.2.4.3 Key Developments
  142.       5.2.4.4 SWOT Analysis
  143.       5.2.4.5 Key Strategies
  144.     5.2.5 Eurofins Scientific (LU)
  145.       5.2.5.1 Financial Overview
  146.       5.2.5.2 Products Offered
  147.       5.2.5.3 Key Developments
  148.       5.2.5.4 SWOT Analysis
  149.       5.2.5.5 Key Strategies
  150.     5.2.6 SGS SA (CH)
  151.       5.2.6.1 Financial Overview
  152.       5.2.6.2 Products Offered
  153.       5.2.6.3 Key Developments
  154.       5.2.6.4 SWOT Analysis
  155.       5.2.6.5 Key Strategies
  156.     5.2.7 Intertek Group plc (GB)
  157.       5.2.7.1 Financial Overview
  158.       5.2.7.2 Products Offered
  159.       5.2.7.3 Key Developments
  160.       5.2.7.4 SWOT Analysis
  161.       5.2.7.5 Key Strategies
  162.     5.2.8 Bureau Veritas (FR)
  163.       5.2.8.1 Financial Overview
  164.       5.2.8.2 Products Offered
  165.       5.2.8.3 Key Developments
  166.       5.2.8.4 SWOT Analysis
  167.       5.2.8.5 Key Strategies
  168.   5.3 Appendix
  169.     5.3.1 References
  170.     5.3.2 Related Reports
  171. 6 LIST OF FIGURES
  172.   6.1 MARKET SYNOPSIS
  173.   6.2 NORTH AMERICA MARKET ANALYSIS
  174.   6.3 US MARKET ANALYSIS BY TEST TYPE
  175.   6.4 US MARKET ANALYSIS BY SAMPLE TYPE
  176.   6.5 US MARKET ANALYSIS BY METHODOLOGY
  177.   6.6 US MARKET ANALYSIS BY END-USE
  178.   6.7 CANADA MARKET ANALYSIS BY TEST TYPE
  179.   6.8 CANADA MARKET ANALYSIS BY SAMPLE TYPE
  180.   6.9 CANADA MARKET ANALYSIS BY METHODOLOGY
  181.   6.10 CANADA MARKET ANALYSIS BY END-USE
  182.   6.11 EUROPE MARKET ANALYSIS
  183.   6.12 GERMANY MARKET ANALYSIS BY TEST TYPE
  184.   6.13 GERMANY MARKET ANALYSIS BY SAMPLE TYPE
  185.   6.14 GERMANY MARKET ANALYSIS BY METHODOLOGY
  186.   6.15 GERMANY MARKET ANALYSIS BY END-USE
  187.   6.16 UK MARKET ANALYSIS BY TEST TYPE
  188.   6.17 UK MARKET ANALYSIS BY SAMPLE TYPE
  189.   6.18 UK MARKET ANALYSIS BY METHODOLOGY
  190.   6.19 UK MARKET ANALYSIS BY END-USE
  191.   6.20 FRANCE MARKET ANALYSIS BY TEST TYPE
  192.   6.21 FRANCE MARKET ANALYSIS BY SAMPLE TYPE
  193.   6.22 FRANCE MARKET ANALYSIS BY METHODOLOGY
  194.   6.23 FRANCE MARKET ANALYSIS BY END-USE
  195.   6.24 RUSSIA MARKET ANALYSIS BY TEST TYPE
  196.   6.25 RUSSIA MARKET ANALYSIS BY SAMPLE TYPE
  197.   6.26 RUSSIA MARKET ANALYSIS BY METHODOLOGY
  198.   6.27 RUSSIA MARKET ANALYSIS BY END-USE
  199.   6.28 ITALY MARKET ANALYSIS BY TEST TYPE
  200.   6.29 ITALY MARKET ANALYSIS BY SAMPLE TYPE
  201.   6.30 ITALY MARKET ANALYSIS BY METHODOLOGY
  202.   6.31 ITALY MARKET ANALYSIS BY END-USE
  203.   6.32 SPAIN MARKET ANALYSIS BY TEST TYPE
  204.   6.33 SPAIN MARKET ANALYSIS BY SAMPLE TYPE
  205.   6.34 SPAIN MARKET ANALYSIS BY METHODOLOGY
  206.   6.35 SPAIN MARKET ANALYSIS BY END-USE
  207.   6.36 REST OF EUROPE MARKET ANALYSIS BY TEST TYPE
  208.   6.37 REST OF EUROPE MARKET ANALYSIS BY SAMPLE TYPE
  209.   6.38 REST OF EUROPE MARKET ANALYSIS BY METHODOLOGY
  210.   6.39 REST OF EUROPE MARKET ANALYSIS BY END-USE
  211.   6.40 APAC MARKET ANALYSIS
  212.   6.41 CHINA MARKET ANALYSIS BY TEST TYPE
  213.   6.42 CHINA MARKET ANALYSIS BY SAMPLE TYPE
  214.   6.43 CHINA MARKET ANALYSIS BY METHODOLOGY
  215.   6.44 CHINA MARKET ANALYSIS BY END-USE
  216.   6.45 INDIA MARKET ANALYSIS BY TEST TYPE
  217.   6.46 INDIA MARKET ANALYSIS BY SAMPLE TYPE
  218.   6.47 INDIA MARKET ANALYSIS BY METHODOLOGY
  219.   6.48 INDIA MARKET ANALYSIS BY END-USE
  220.   6.49 JAPAN MARKET ANALYSIS BY TEST TYPE
  221.   6.50 JAPAN MARKET ANALYSIS BY SAMPLE TYPE
  222.   6.51 JAPAN MARKET ANALYSIS BY METHODOLOGY
  223.   6.52 JAPAN MARKET ANALYSIS BY END-USE
  224.   6.53 SOUTH KOREA MARKET ANALYSIS BY TEST TYPE
  225.   6.54 SOUTH KOREA MARKET ANALYSIS BY SAMPLE TYPE
  226.   6.55 SOUTH KOREA MARKET ANALYSIS BY METHODOLOGY
  227.   6.56 SOUTH KOREA MARKET ANALYSIS BY END-USE
  228.   6.57 MALAYSIA MARKET ANALYSIS BY TEST TYPE
  229.   6.58 MALAYSIA MARKET ANALYSIS BY SAMPLE TYPE
  230.   6.59 MALAYSIA MARKET ANALYSIS BY METHODOLOGY
  231.   6.60 MALAYSIA MARKET ANALYSIS BY END-USE
  232.   6.61 THAILAND MARKET ANALYSIS BY TEST TYPE
  233.   6.62 THAILAND MARKET ANALYSIS BY SAMPLE TYPE
  234.   6.63 THAILAND MARKET ANALYSIS BY METHODOLOGY
  235.   6.64 THAILAND MARKET ANALYSIS BY END-USE
  236.   6.65 INDONESIA MARKET ANALYSIS BY TEST TYPE
  237.   6.66 INDONESIA MARKET ANALYSIS BY SAMPLE TYPE
  238.   6.67 INDONESIA MARKET ANALYSIS BY METHODOLOGY
  239.   6.68 INDONESIA MARKET ANALYSIS BY END-USE
  240.   6.69 REST OF APAC MARKET ANALYSIS BY TEST TYPE
  241.   6.70 REST OF APAC MARKET ANALYSIS BY SAMPLE TYPE
  242.   6.71 REST OF APAC MARKET ANALYSIS BY METHODOLOGY
  243.   6.72 REST OF APAC MARKET ANALYSIS BY END-USE
  244.   6.73 SOUTH AMERICA MARKET ANALYSIS
  245.   6.74 BRAZIL MARKET ANALYSIS BY TEST TYPE
  246.   6.75 BRAZIL MARKET ANALYSIS BY SAMPLE TYPE
  247.   6.76 BRAZIL MARKET ANALYSIS BY METHODOLOGY
  248.   6.77 BRAZIL MARKET ANALYSIS BY END-USE
  249.   6.78 MEXICO MARKET ANALYSIS BY TEST TYPE
  250.   6.79 MEXICO MARKET ANALYSIS BY SAMPLE TYPE
  251.   6.80 MEXICO MARKET ANALYSIS BY METHODOLOGY
  252.   6.81 MEXICO MARKET ANALYSIS BY END-USE
  253.   6.82 ARGENTINA MARKET ANALYSIS BY TEST TYPE
  254.   6.83 ARGENTINA MARKET ANALYSIS BY SAMPLE TYPE
  255.   6.84 ARGENTINA MARKET ANALYSIS BY METHODOLOGY
  256.   6.85 ARGENTINA MARKET ANALYSIS BY END-USE
  257.   6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY TEST TYPE
  258.   6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY SAMPLE TYPE
  259.   6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY METHODOLOGY
  260.   6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END-USE
  261.   6.90 MEA MARKET ANALYSIS
  262.   6.91 GCC COUNTRIES MARKET ANALYSIS BY TEST TYPE
  263.   6.92 GCC COUNTRIES MARKET ANALYSIS BY SAMPLE TYPE
  264.   6.93 GCC COUNTRIES MARKET ANALYSIS BY METHODOLOGY
  265.   6.94 GCC COUNTRIES MARKET ANALYSIS BY END-USE
  266.   6.95 SOUTH AFRICA MARKET ANALYSIS BY TEST TYPE
  267.   6.96 SOUTH AFRICA MARKET ANALYSIS BY SAMPLE TYPE
  268.   6.97 SOUTH AFRICA MARKET ANALYSIS BY METHODOLOGY
  269.   6.98 SOUTH AFRICA MARKET ANALYSIS BY END-USE
  270.   6.99 REST OF MEA MARKET ANALYSIS BY TEST TYPE
  271.   6.100 REST OF MEA MARKET ANALYSIS BY SAMPLE TYPE
  272.   6.101 REST OF MEA MARKET ANALYSIS BY METHODOLOGY
  273.   6.102 REST OF MEA MARKET ANALYSIS BY END-USE
  274.   6.103 KEY BUYING CRITERIA OF CHEMICALS AND MATERIALS
  275.   6.104 RESEARCH PROCESS OF MRFR
  276.   6.105 DRO ANALYSIS OF CHEMICALS AND MATERIALS
  277.   6.106 DRIVERS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  278.   6.107 RESTRAINTS IMPACT ANALYSIS: CHEMICALS AND MATERIALS
  279.   6.108 SUPPLY / VALUE CHAIN: CHEMICALS AND MATERIALS
  280.   6.109 CHEMICALS AND MATERIALS, BY TEST TYPE, 2024 (% SHARE)
  281.   6.110 CHEMICALS AND MATERIALS, BY TEST TYPE, 2024 TO 2035 (USD Billion)
  282.   6.111 CHEMICALS AND MATERIALS, BY SAMPLE TYPE, 2024 (% SHARE)
  283.   6.112 CHEMICALS AND MATERIALS, BY SAMPLE TYPE, 2024 TO 2035 (USD Billion)
  284.   6.113 CHEMICALS AND MATERIALS, BY METHODOLOGY, 2024 (% SHARE)
  285.   6.114 CHEMICALS AND MATERIALS, BY METHODOLOGY, 2024 TO 2035 (USD Billion)
  286.   6.115 CHEMICALS AND MATERIALS, BY END-USE, 2024 (% SHARE)
  287.   6.116 CHEMICALS AND MATERIALS, BY END-USE, 2024 TO 2035 (USD Billion)
  288.   6.117 BENCHMARKING OF MAJOR COMPETITORS
  289. 7 LIST OF TABLES
  290.   7.1 LIST OF ASSUMPTIONS
  291.     7.1.1
  292.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  293.     7.2.1 BY TEST TYPE, 2025-2035 (USD Billion)
  294.     7.2.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  295.     7.2.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  296.     7.2.4 BY END-USE, 2025-2035 (USD Billion)
  297.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  298.     7.3.1 BY TEST TYPE, 2025-2035 (USD Billion)
  299.     7.3.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  300.     7.3.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  301.     7.3.4 BY END-USE, 2025-2035 (USD Billion)
  302.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  303.     7.4.1 BY TEST TYPE, 2025-2035 (USD Billion)
  304.     7.4.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  305.     7.4.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  306.     7.4.4 BY END-USE, 2025-2035 (USD Billion)
  307.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  308.     7.5.1 BY TEST TYPE, 2025-2035 (USD Billion)
  309.     7.5.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  310.     7.5.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  311.     7.5.4 BY END-USE, 2025-2035 (USD Billion)
  312.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  313.     7.6.1 BY TEST TYPE, 2025-2035 (USD Billion)
  314.     7.6.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  315.     7.6.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  316.     7.6.4 BY END-USE, 2025-2035 (USD Billion)
  317.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  318.     7.7.1 BY TEST TYPE, 2025-2035 (USD Billion)
  319.     7.7.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  320.     7.7.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  321.     7.7.4 BY END-USE, 2025-2035 (USD Billion)
  322.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  323.     7.8.1 BY TEST TYPE, 2025-2035 (USD Billion)
  324.     7.8.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  325.     7.8.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  326.     7.8.4 BY END-USE, 2025-2035 (USD Billion)
  327.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  328.     7.9.1 BY TEST TYPE, 2025-2035 (USD Billion)
  329.     7.9.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  330.     7.9.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  331.     7.9.4 BY END-USE, 2025-2035 (USD Billion)
  332.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  333.     7.10.1 BY TEST TYPE, 2025-2035 (USD Billion)
  334.     7.10.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  335.     7.10.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  336.     7.10.4 BY END-USE, 2025-2035 (USD Billion)
  337.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  338.     7.11.1 BY TEST TYPE, 2025-2035 (USD Billion)
  339.     7.11.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  340.     7.11.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  341.     7.11.4 BY END-USE, 2025-2035 (USD Billion)
  342.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  343.     7.12.1 BY TEST TYPE, 2025-2035 (USD Billion)
  344.     7.12.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  345.     7.12.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  346.     7.12.4 BY END-USE, 2025-2035 (USD Billion)
  347.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  348.     7.13.1 BY TEST TYPE, 2025-2035 (USD Billion)
  349.     7.13.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  350.     7.13.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  351.     7.13.4 BY END-USE, 2025-2035 (USD Billion)
  352.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  353.     7.14.1 BY TEST TYPE, 2025-2035 (USD Billion)
  354.     7.14.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  355.     7.14.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  356.     7.14.4 BY END-USE, 2025-2035 (USD Billion)
  357.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  358.     7.15.1 BY TEST TYPE, 2025-2035 (USD Billion)
  359.     7.15.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  360.     7.15.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  361.     7.15.4 BY END-USE, 2025-2035 (USD Billion)
  362.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  363.     7.16.1 BY TEST TYPE, 2025-2035 (USD Billion)
  364.     7.16.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  365.     7.16.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  366.     7.16.4 BY END-USE, 2025-2035 (USD Billion)
  367.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  368.     7.17.1 BY TEST TYPE, 2025-2035 (USD Billion)
  369.     7.17.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  370.     7.17.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  371.     7.17.4 BY END-USE, 2025-2035 (USD Billion)
  372.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  373.     7.18.1 BY TEST TYPE, 2025-2035 (USD Billion)
  374.     7.18.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  375.     7.18.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  376.     7.18.4 BY END-USE, 2025-2035 (USD Billion)
  377.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  378.     7.19.1 BY TEST TYPE, 2025-2035 (USD Billion)
  379.     7.19.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  380.     7.19.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  381.     7.19.4 BY END-USE, 2025-2035 (USD Billion)
  382.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  383.     7.20.1 BY TEST TYPE, 2025-2035 (USD Billion)
  384.     7.20.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  385.     7.20.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  386.     7.20.4 BY END-USE, 2025-2035 (USD Billion)
  387.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  388.     7.21.1 BY TEST TYPE, 2025-2035 (USD Billion)
  389.     7.21.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  390.     7.21.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  391.     7.21.4 BY END-USE, 2025-2035 (USD Billion)
  392.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  393.     7.22.1 BY TEST TYPE, 2025-2035 (USD Billion)
  394.     7.22.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  395.     7.22.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  396.     7.22.4 BY END-USE, 2025-2035 (USD Billion)
  397.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  398.     7.23.1 BY TEST TYPE, 2025-2035 (USD Billion)
  399.     7.23.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  400.     7.23.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  401.     7.23.4 BY END-USE, 2025-2035 (USD Billion)
  402.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  403.     7.24.1 BY TEST TYPE, 2025-2035 (USD Billion)
  404.     7.24.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  405.     7.24.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  406.     7.24.4 BY END-USE, 2025-2035 (USD Billion)
  407.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  408.     7.25.1 BY TEST TYPE, 2025-2035 (USD Billion)
  409.     7.25.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  410.     7.25.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  411.     7.25.4 BY END-USE, 2025-2035 (USD Billion)
  412.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  413.     7.26.1 BY TEST TYPE, 2025-2035 (USD Billion)
  414.     7.26.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  415.     7.26.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  416.     7.26.4 BY END-USE, 2025-2035 (USD Billion)
  417.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  418.     7.27.1 BY TEST TYPE, 2025-2035 (USD Billion)
  419.     7.27.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  420.     7.27.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  421.     7.27.4 BY END-USE, 2025-2035 (USD Billion)
  422.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  423.     7.28.1 BY TEST TYPE, 2025-2035 (USD Billion)
  424.     7.28.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  425.     7.28.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  426.     7.28.4 BY END-USE, 2025-2035 (USD Billion)
  427.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  428.     7.29.1 BY TEST TYPE, 2025-2035 (USD Billion)
  429.     7.29.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  430.     7.29.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  431.     7.29.4 BY END-USE, 2025-2035 (USD Billion)
  432.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  433.     7.30.1 BY TEST TYPE, 2025-2035 (USD Billion)
  434.     7.30.2 BY SAMPLE TYPE, 2025-2035 (USD Billion)
  435.     7.30.3 BY METHODOLOGY, 2025-2035 (USD Billion)
  436.     7.30.4 BY END-USE, 2025-2035 (USD Billion)
  437.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  438.     7.31.1
  439.   7.32 ACQUISITION/PARTNERSHIP
  440.     7.32.1

Chemicals and Materials Market Segmentation

Chemicals and Materials By Test Type (USD Billion, 2025-2035)

  • Total Coliforms
  • E. coli
  • Fecal Enterococci
  • Legionella
  • Pseudomonas
  • Others

Chemicals and Materials By Sample Type (USD Billion, 2025-2035)

  • Water
  • Wastewater
  • Industrial Water
  • Groundwater
  • Drinking Water
  • Others

Chemicals and Materials By Methodology (USD Billion, 2025-2035)

  • Culture-Based Methods
  • Molecular Methods
  • Immunological Methods
  • Others

Chemicals and Materials By End-Use (USD Billion, 2025-2035)

  • Municipal Water Treatment
  • Industrial Water Treatment
  • Food and Beverage Industry
  • Healthcare Industry
  • Research and Development
  • Others

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions